FDA Report Suggests Delayed, Incomplete CPAP Recall
In a recent report from the FDA, the safety regulator observes that the Philips CPAP machine recall may not have been complete. The June 2021 recall involved several of the company’s CPAP and ventilator devices equipped with allegedly toxic sound abatement foam known as PE-PUR foam. However, the recall may not have included all of the breathing machines containing the allegedly defective foam.
Over time, the foam inside the machines breaks down, releasing harmful particles that may cause health problems if ingested. Consumers have filed CPAP and BiPAP lawsuits against Philips alleging the company knew of the health risks the foam had, but did not warn consumers.
The FDA report also suggests that the recall may have been years overdue, noting foam degradation complaints/issues Philips received in or prior to 2015, and results from various test reports. Since 2008, at least 222,000 complaints from consumers have been identified that mention problems with the foam.
Do You Have a Valid Philips CPAP/Bi-PAP Claim?
If you or a loved one used any of the following Philips PAP models for at least one year and experienced any of the above conditions, call our law firm for a free consultation:
- DreamStation CPAP, Auto CPAP, and BiPAP
- DreamStation Go CPAP and APAP
- Dorma 400 and 500 CPAP
- REMStar SE Auto CPAP
